Evidence map›Paper›PMID 38052940›Full record

ArticleJournal of exposure science & environmental epidemiology2024

Monitoring of over-the-counter (OTC) and COVID-19 treatment drugs complement wastewater surveillance of SARS-CoV-2.

Cheng-Shiuan Lee, Mian Wang, Deepak Nanjappa, Yi-Ta Lu, Jaymie Meliker, Sean Clouston, Christopher J Gobler, Arjun K Venkatesan

Open access · hybridAbstract read
In one paragraph

Article in Journal of exposure science & environmental epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Wastewater-based epidemiology to assess environmentally influenced disease.Journal of exposure science & environmental epidemiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Cheng-Shiuan LeeNew York State Center for Clean Water Technology, Stony Brook University, Stony Brook, NY, 11794, USA.
Mian WangNew York State Center for Clean Water Technology, Stony Brook University, Stony Brook, NY, 11794, USA.
Deepak NanjappaNew York State Center for Clean Water Technology, Stony Brook University, Stony Brook, NY, 11794, USA.
Yi-Ta LuDepartment of Human Behavior, Ecology and Culture, Max Planck Institute for Evolutionary Anthropology, 04103, Leipzig, Germany.
Jaymie MelikerProgram in Public Health, Department of Family, Population & Preventive Medicine, Stony Brook University Medical Center, Stony Brook, NY, 11794, USA.
Sean CloustonProgram in Public Health, Department of Family, Population & Preventive Medicine, Stony Brook University Medical Center, Stony Brook, NY, 11794, USA.
Christopher J GoblerNew York State Center for Clean Water Technology, Stony Brook University, Stony Brook, NY, 11794, USA.
Arjun K VenkatesanNew York State Center for Clean Water Technology, Stony Brook University, Stony Brook, NY, 11794, USA. arjun.venkatesan@njit.edu.ORCID 0000-0001-9760-9004
Stony Brook University · USStony Brook University Hospital · USMax Planck Institute for Evolutionary Anthropology · DENew Jersey Institute of Technology · USResearch Center for Environmental Changes, Academia Sinica · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe application of wastewater-based epidemiology to track the outbreak and prevalence of coronavirus disease (COVID-19) in communities has been tested and validated by several researchers across the globe. However, the RNA-based surveillance has its inherent limitations and uncertainties.

objectiveThis study aims to complement the ongoing wastewater surveillance efforts by analyzing other chemical biomarkers in wastewater to help assess community response (hospitalization and treatment) during the pandemic (2020-2021).

methodsWastewater samples (n = 183) were collected from the largest wastewater treatment facility in Suffolk County, NY, USA and analyzed for COVID-19 treatment drugs (remdesivir, chloroquine, and hydroxychloroquine (HCQ)) and their human metabolites. We additionally monitored 26 pharmaceuticals including common over-the-counter (OTC) drugs. Lastly, we developed a Bayesian model that uses viral RNA, COVID-19 treatment drugs, and pharmaceuticals data to predict the confirmed COVID-19 cases within the catchment area.

resultsThe viral RNA levels in wastewater tracked the actual COVID-19 case numbers well as expected. COVID-19 treatment drugs were detected with varying frequency (9-100%) partly due to their instability in wastewater. We observed a significant correlation (R = 0.30, p < 0.01) between the SARS-CoV-2 genes and desethylhydroxychloroquine (DHCQ, metabolite of HCQ). Remdesivir levels peaked immediately after the Emergency Use Authorization approved by the FDA. Although, 13 out of 26 pharmaceuticals assessed were consistently detected (DF = 100%, n = 111), only acetaminophen was significantly correlated with viral loads, especially when the Omicron variant was dominant. The Bayesian models were capable of reproducing the temporal trend of the confirmed cases. IMPACT: In this study, for the first time, we measured COVID-19 treatment and pharmaceutical drugs and their metabolites in wastewater to complement ongoing COVID-19 viral RNA surveillance efforts. Our results highlighted that, although the COVID-19 treatment drugs were not very stable in wastewater, their detection matched with usage trends in the community. Acetaminophen, an OTC drug, was significantly correlated with viral loads and confirmed cases, especially when the Omicron variant was dominant. A Bayesian model was developed which could predict COVID-19 cases more accurately when incorporating other drugs data along with viral RNA levels in wastewater.

Indexed as

COVID-19COVID-19 Drug TreatmentHydroxychloroquineNonprescription DrugsSARS-CoV-2WastewaterAdenosine MonophosphateAlanineAntiviral AgentsBayes TheoremChloroquineHumansRNA, ViralWastewater-Based Epidemiological MonitoringAdenosine MonophosphateAlanineAntiviral AgentsChloroquineHydroxychloroquineNonprescription DrugsremdesivirRNA, ViralWastewaterAcetaminophenBayesian modelsCOVID-19 pandemicRemdesivirWastewater-based epidemiology

Identifiers

PMID38052940
PMCPMC11222153
OpenAlexW4389348831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.